Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options

INTRODUCTION: A scaled-up treatment cascade with direct-acting antiviral (DAA) therapy is necessary to achieve global WHO targets for hepatitis C virus (HCV) elimination in Malaysia. Recently, limited access to sofosbuvir/daclatasvir (SOF/DAC) is available through compulsory licensing, with access t...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzeri, Amirah, Dahlui, Maznah, Mohamed, Rosmawati, McDonald, Scott Alexander, Jaafar, Hafiz, Shabaruddin, Fatiha Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015636/
https://www.ncbi.nlm.nih.gov/pubmed/36935675
http://dx.doi.org/10.3389/fpubh.2023.1114560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015636/
https://www.ncbi.nlm.nih.gov/pubmed/36935675
http://dx.doi.org/10.3389/fpubh.2023.1114560

Ejemplares similares